Found 42 matching trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
PHASE1This study examines two doses of Ranibizumab (0.5mg and 1.0mg) for the trea...
Location
South Coast Retina
Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
PHASE3Treatment of diabetic macular edema with perifoveal focal/grid laser coagul...
Location
Department of Ophthalmology, Medical University of Vienna
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept
PHASE4This study will examine the use of Aflibercept in patients with exudative m...
Location
Cole Eye Institute, Cleveland Clinic
The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion
NAAge related macula degeneration is one of the most common sight threatening...
Location
Department of Clinical Pharmacology, Medical University of Vienna
Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema
PHASE4The purpose of this study is to investigate the change in macular edema and...
Location
Dept. of Ophthalmology, Medical University of Vienna
Manta Study: Avastin Versus Lucentis in Age Related Macular Degeneration
PHASE3Angiogenesis plays a key role in the development of choroidal neovasculariz...
Location
Ludwig Boltzmann Institute for Retinology and Biomicroscopic Lasersurgery
Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients
N/APatients with AMD who are being or have been treated with eye injections of...
Location
Ophthalmic Consultants Boston
Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.
PHASE1The purpose of the study is to determine the effectiveness of Ranibizumab 0...
Location
Northern California Retina Vitreous Associates
Refractive Error and Biometry in Retinopathy of Prematurity
N/AThe investigators compared long-term refractive and biometric outcomes in c...
Location
Multiple Locations
Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF
PHASE2This study is a double-masked, randomized, placebo-controlled study of the ...
Location
Multiple Locations